Lymphoma, B-Cell, Marginal Zone
Showing 9976 - 10000 of >10,000
Oropharyngeal Dysphagia Trial in Sacramento, San Francisco (Autologous Muscle Derived Cells for Gastro-Intestinal Repair
Recruiting
- Oropharyngeal Dysphagia
- Autologous Muscle Derived Cells for Gastro-Intestinal Repair (AMDC-GIR)
- Placebo
-
Sacramento, California
- +1 more
Jun 13, 2022
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Houston (6 Minute Walk Functional Test, Behavioral
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- 6 Minute Walk Functional Test
- +3 more
-
Houston, Texas
- +1 more
Jan 6, 2023
Small-cell Lung Cancer Trial in Worldwide (Berzosertib, Topotecan)
Active, not recruiting
- Small-cell Lung Cancer
-
Santa Rosa, California
- +47 more
Jun 24, 2022
Lip, Oral Cavity Squamous Cell Carcinoma, Pharynx Trial in Columbus, Philadelphia (biological, procedure, other)
Recruiting
- Lip
- +4 more
- Nivolumab
- +3 more
-
Columbus, Ohio
- +1 more
Oct 25, 2021
Evaluate Safety of McGhan Single Lumen Gel-Filled Breast
Completed
- Breast Augmentation
- Breast Reconstruction
-
Beijing, Beijing, China
- +5 more
Sep 18, 2020
Anesthesia Trial in Cairo (Nerve block)
Recruiting
- Anesthesia
- Nerve block
-
Cairo, Nasr City, EgyptSamar Soliman
Nov 12, 2021
Right Ventricular Function Among Chronic Lung Disease
Not yet recruiting
- Right Ventricular Function
- Echocardiographic examination
- (no location specified)
Nov 14, 2023
Safety and Efficacy Trial in Suzhou (anti-CD19 and anti-BCMA CAR, Immunomodulatory drugs)
Recruiting
- Safety and Efficacy
- anti-CD19 and anti-BCMA CAR
- Immunomodulatory drugs
-
Suzhou, Jiangsu, ChinaFirst Affiliated Hospital, Soochow University
May 17, 2021
Melanoma, Renal Cell Carcinoma, Brain Metastases Trial in New Haven (Pembrolizumab, Lenvatinib)
Recruiting
- Melanoma
- +6 more
-
New Haven, ConnecticutYale University
Feb 18, 2022
Advanced/Metastatic Non-Small Cell Lung Cancer
Recruiting
- Carcinoma, Non-Small-Cell Lung
-
Research Triangle Park, North CarolinaRTI Health Solutions
Feb 11, 2022
Durvalumab in Combination With Standard Chemotherapy of
Recruiting
- Small-cell Lung Cancer
- Extensive-stage Small-cell Lung Cancer
-
Néo Fáliro, GreeceMetropolitan Hospital
Mar 7, 2023
COVID-19, SARS-CoV-2 Infection Trial in Iloilo City (Recombinant COVID-19 Vaccine (Sf9 Cell), COVID-19 Vaccine (Vero Cell),
Recruiting
- COVID-19
- SARS-CoV-2 Infection
- Recombinant COVID-19 Vaccine (Sf9 Cell)
- COVID-19 Vaccine (Vero Cell), Inactivated
-
Iloilo City, PhilippinesIloilo Doctors Hospital
Jul 18, 2022
Coronavirus Infection Trial in Liège (Mesenchymal stromal cells)
Recruiting
- Coronavirus Infection
- Mesenchymal stromal cells
-
Liège, BelgiumCHU de Liège
Sep 19, 2022
Lymphoma Trial in Worldwide (biological, drug, radiation)
Unknown status
- Lymphoma
- bleomycin sulfate
- +6 more
-
Antwerpen, Belgium
- +120 more
Feb 2, 2021
Post Partum Depression, Perinatal Depression Trial (Stress reduction program 'A', Stress reduction program 'B')
Not yet recruiting
- Post Partum Depression
- Perinatal Depression
- Stress reduction program 'A'
- Stress reduction program 'B'
- (no location specified)
May 31, 2022
Metastatic Castration-Resistant Prostate Cancer Trial in Worldwide (biological, drug, other)
Recruiting
- Metastatic Castration-Resistant Prostate Cancer
- Pembrolizumab 200 mg
- +11 more
-
Los Angeles, California
- +30 more
Aug 12, 2022
Solid Organ Transplant Trial in Toronto (iPeer2Peer Support Mentorship Program)
Enrolling by invitation
- Solid Organ Transplant
- iPeer2Peer Support Mentorship Program
-
Toronto, Ontario, CanadaHospital for Sick Children
Dec 12, 2022
Dental Restoration Failures Trial in Istanbul (To evaluate the clinical performance of indirect resin composite restorations,
Completed
- Dental Restoration Failures
- To evaluate the clinical performance of indirect resin composite restorations, which were luted with two different resin cement, in posterior teeth for up to 5 years.
-
Istanbul, TurkeyYelda Erdem Hepsenoglu
Sep 20, 2022
Oral Squamous Cell Carcinoma Trial (Tislelizumab, Albumin paclitaxel, Cisplatin)
Not yet recruiting
- Oral Squamous Cell Carcinoma
- Tislelizumab
- +3 more
- (no location specified)
May 7, 2023
Follicular Lymphoma Trial in Worldwide (Duvelisib, Placebo, Rituximab)
Terminated
- Follicular Lymphoma
- Duvelisib
- +2 more
-
Frankston, Victoria, Australia
- +4 more
Mar 15, 2021
Long Term Follow up of Recipients of Functional Islet Allografts
Recruiting
- Type 1 Diabetes Mellitus
-
Miami, FloridaDiabetes Research Institute
Mar 1, 2022
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, NF1 Mutation Positive Malignant Peripheral Nerve Sheath Tumor
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +3 more
- Pharmacodynamic Study
- Telaglenastat Hydrochloride
-
Birmingham, Alabama
- +30 more
Sep 1, 2022
People Undergoing Hematopoietic Stem Cell Transplantation
Recruiting
- Hematopoietic Stem Cell Transplantation
- Tissue Donors
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022